Cargando…

Immunohaematological reference values for HIV-negative healthy adults in Botswana

BACKGROUND: Clinical laboratories in Botswana have relied entirely on the reference intervals for normal immunohaematological values provided by manufacturers’ kits and textbooks. OBJECTIVES: The aim of this study was to determine the means, medians, 2.5th and 97.5th percentile reference intervals,...

Descripción completa

Detalles Bibliográficos
Autores principales: Mine, Madisa, Moyo, Sikhulile, Stevens, Penny, Michael, Kurt, Novitsky, Vladimir, Makhaola, Kgomotso, Asmelash, Aida, Molefhabangwe, S’khatele, Woldegabriel, Elias, Mothowaeng, Gaseboloke, Maruta, Talkmore, Kamhukamwe, Charity, Mangwendeza, Phibeon M., Holmes-Pretorius, Molly, Mtoni, Isaac, Motswaledi, Modisa, Musonda, Rosemary, Ndwapi, Ndwapi, Makhema, Joseph, Marlink, Richard, Seipone, Khumo, Gaolathe, Tendani, Essex, Max
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AOSIS OpenJournals 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682757/
https://www.ncbi.nlm.nih.gov/pubmed/23772402
http://dx.doi.org/10.4102/ajlm.v1i1.5
Descripción
Sumario:BACKGROUND: Clinical laboratories in Botswana have relied entirely on the reference intervals for normal immunohaematological values provided by manufacturers’ kits and textbooks. OBJECTIVES: The aim of this study was to determine the means, medians, 2.5th and 97.5th percentile reference intervals, for normal immunohaematological values in healthy adults in Botswana. METHOD: A total of 261 healthy participants comprising 126 men (48%) and 135 (52%) women were enrolled in the southern part of Botswana, and immunological and haematological laboratory parameters were measured. RESULTS: The mean age was 28.8 (95% Confidence Interval [CI] 27.7–29.8) years, with a median of 27 years and a range 18–66 years. The mean haemoglobin level was significantly lower for women (12.4 g/dL; 95% CI 12.1% – 12.7%) than men (15.1 g/dL; 95% CI 14.9% – 15.3%). The women’s haemoglobin reference values (9.0 g/dL – 15.0 g/dL) levels were lower than observed in predominantly White populations (12.0 g/dL – 16.0 g/dL), but comparable with regional consensus reference intervals (9.5 g/dL – 15.8 g/dL) recently defined for East and Southern Africa. CONCLUSION: The established values provide an important tool for patient management and could influence decisions on inclusion of participants and adverse events in clinical trials conducted locally.